Adverse Event Reporting
| VAERS ID | 903123 |
|---|---|
| Gender | Female |
| Age | 37 |
| StateCode | AK |
| Pharmaceutical Company | PFIZER\BIONTECH |
| Lot Number | EK5730 |
| Number of vaccinations | 1 |
| Vaccinated | 2020-12-16 |
| Onset | 2020-12-16 |
| Condition | Life Threatening |
Symptoms
- Dizziness
- Chest discomfort
- Dyspnoea
- Palpitations
- Blood glucose normal
- Injection site pain
- Rash
- Rash erythematous
- SARS-CoV-2 test negative
- Activated partial thromboplastin time shortened
- Alanine aminotransferase normal
- Anion gap
- Aspartate aminotransferase normal
- Basophil count normal
- Basophil percentage decreased
- Blood albumin normal
- Blood alkaline phosphatase normal
- Blood bilirubin normal
- Blood calcium normal
- Blood chloride normal
- Blood magnesium normal
- Blood osmolarity decreased
- Blood potassium decreased
- Blood sodium normal
- Blood urea nitrogen/creatinine ratio
- Blood urea normal
- C-reactive protein increased
- Eosinophil count normal
- Eosinophil percentage decreased
- Fibrin D dimer
- Glomerular filtration rate decreased
- Haematocrit normal
- Haemoglobin normal
- Immature granulocyte count increased
- International normalised ratio normal
- Lymphocyte count normal
- Lymphocyte percentage
- Mean cell haemoglobin concentration decreased
- Mean cell haemoglobin normal
- Mean cell volume normal
- Mean platelet volume increased
- Monocyte count normal
- Monocyte percentage
- N-terminal prohormone brain natriuretic peptide normal
- Neutrophil count normal
- Neutrophil percentage
- Platelet count normal
- Protein total normal
- Red blood cell count normal
- Red blood cell sedimentation rate increased
- Red cell distribution width normal
- Troponin T normal
- White blood cell count normal
Current Illness
none
Preexisting Conditions
Pulmonary Hypertension Obesity Li-Fraumeni Syndrome H/o Breast Cancer
Other Medications
Eliquis, Bumetanide
Previous Vaccinations
Allergies
Latex, Propofol, Nickel, Almonds
Laboratory Data
WBC 9.
88 HGB 14.
4 HCT 40.
8 Platelet Count 292 RBC 4.
81 MCV 84.
8 MCH 29.
9 MCHC 29.
9 RDW 12.
5 MPV 10.
8 Sedimentation Rate 37 Diff Absolute Neutrophils 6.
44 Absolute Imm.
Granulocyte 0.
01 Absolute Lymphocytes - CBC 2.
94 Absolute Monocytes - 0.
38 Absolute Eosinophils - 0.
08 Absolute Basophils - 0.
03 Neutrophils 65.
2 % Immature Granulocyte 0.
1% Lymphocytes 29.
8% Monocytes 3.
8% Eosinophils 0.
8% Basophils 0.
3% Coagulation Prothrombin Time 9.
8 sec INR 1.
0 Partial Thromboplastin Time 26.
4 sec D-DIMER,QUANT 0.
67mg/L ROUTINE CHEMISTRY NT-proBNP 29 BUN/Creatinine Ratio 11.
4 Osmolality Calculated 277 GFR (estimated) 67 Sodium 139 Potassium 3.
0 Chloride 98 CO2 30 BUN 10.
7 Creatinine 0.
94 Glucose Level 100 Calcium 9.
5 Magnesium 1.
9 Protein,Total 7.
4 Albumin 4.
5 AST (SGOT) 18 ALT (SGPT) 24 Alkaline Phosphatase 94 Bilirubin, Total 0.
8 CRP, High-Sensitivity 1.
72 Anion Gap 14 CARDIAC ISOENZYMES Troponin T <0.
01 Molecular Diagnostics SARS-CoV-2 - negatieve
Write-up
About 5 minutes after the vaccine developed chest tightness, increased work of breathing, palpitations and severe dizzyness.
Transferred to the ED where i received oxygen, IV benadryl, IV fluids and monitoring.
Released after about 4 hours and continue to take benadryl 50 mg PO q 4 hours.
Also developed red facial rash (unknown time) Pain at injection site began the morning after the injection.